Stereotaxis Clocks 28% Revenue Growth In Q2 On Continued Demand For Robotic Technology
Stereotaxis, Inc. (AMEX: STXS) reported Q2 revenues of $7.859 million,
Watching Super Micro Computer; Spruce Point Management Issues Short Report
https://www.sprucepointcap.com/super-micro-inc/
Related Posts
IBM Sees FY22 Consolidated Free Cash Flow Of ~$10B
Full-Year 2022 Expectations
Revenue growth: The company continues to expect constant currency revenue growth at the high end of its mid-single digit model. The company also expects an additional 3.5 point contribution
Performance Comparison: Broadcom And Competitors In Semiconductors & Semiconductor Equipment Industry
In today’s rapidly changing and fiercely competitive business landscape, it is essential for investors and industry enthusiasts to…
Jasper Therapeutics Announces Development Prioritization of Briquilimab In Chronic Diseases
Jasper Therapeutics Inc (NASDAQ:JSPR) will focus on developing its lead product candidate, briquilimab (formerly JSP191), in chronic diseases and stem…